The American Society of Clinical Oncology has issued new clinical guidance for best treating patients with gastrointestinal cancer amidst a nationwide shortage of carboplatin and cisplatin.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe